Companies  » Health Care

Ranbaxy provisions for settlement with US

The company continues in red due to the provision for settlement with US govt

Pharma stocks could rise another 15-20 per cent

28 Jul 2014

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine ...

Weekly update: Market retreats from record highs on profit-booking

26 Jul 2014

Markets were on a firm footing for the week ended July 25, supported by continuous buying from foreign institutional buyers and robust global ...

Pharma firms go to HC against use of special power for price cuts

26 Jul 2014

According to a source, the matter is expected to come for hearing at the court on July 30

Strides net up 12-fold

25 Jul 2014

Net sales up 25% to Rs 188 cr, co also cites spate of USFDA approvals for better performance

Biocon ups R&D expenses by 15%

25 Jul 2014

Bangalore-based biotech major Biocon Ltd has increased gross R&D expenditure by nearly 15 per cent.

Strides Arcolab Q1 net jumps over 12-fold to Rs 26.79 crore

25 Jul 2014

Drug maker Strides Arcolab today reported over 12-fold jump in standalone net profit to Rs 26.79 crore for the quarter ended June 30 on improved ...

Pharma shares in demand; Healthcare index hits new high

25 Jul 2014

Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE.

Novartis India Q1 net up 3% at Rs 14.31 cr

25 Jul 2014

Drug firm Novartis India today reported a 3.17 per cent rise in its standalone net profit to Rs 14.31 crore for the quarter ended June 30, 2014.

Cipla appoints Adil Zainulbhai as independent director

25 Jul 2014

The Mumbai-based Cipla has appointed Adil Zainulbhai as an independent director on the board. Adil Zainulbhai retired as chairman of McKinsey ...

Biocon declines 5% as Q1 growth lags estimates

25 Jul 2014

The flagship biopharma business grew by hardly 1% to Rs 549 crore in Q1 from Rs 543 crore in year ago quarter.

Glenmark Pharma surges on strong June quarter results

25 Jul 2014

EBITDA or operating profit margins improved 300 basis points to 23% from 20%.

Ranbaxy inks pact with Cipher; stock hits 52-week high

25 Jul 2014

Sun Pharma also rallied by nearly 3% to Rs 769, its new high on National Stock Exchange.

FDA alert on IPCA Labs, US export halted from MP unit

25 Jul 2014

The company had received certain inspection observations in Form 483 from the US FDA

Biocon Q1 net up 9%

25 Jul 2014

Bangalore-based publicly held biotechnology major Biocon has reported a decent nine per cent growth in net profit to Rs 103 crore for the first ...

Glenmark continues to struggle in US

24 Jul 2014

Analysts peg FY15 sales growth at 18-20%; prospects to improve in FY16 after cholesterol drug launch

Granules India Q1 net up 56%

24 Jul 2014

Reports profit of Rs 23 cr for the quarter ended June 2014 from Rs 15 cr in the corresponding quarter last year

Apollo Hospitals, Strand Life partner for genomic tests

24 Jul 2014

Tests would be offered in cardiology, oncology, rare genetic disorders and heritable eye diseases for Apollo patients

Ranbaxy inks pact with Cipher to sell acne drug in Brazil

24 Jul 2014

Drug major Ranbaxy today said it has inked a licensing pact with Canada's Cipher Pharmaceuticals Inc to exclusively market its isotretinoin ...

Quick Links


Back to Top